Nexalin Technology (NXL) Amortizatization of Intangibles (2023 - 2026)
Nexalin Technology (NXL) posted quarterly Amortizatization of Intangibles of $6736.0 for Q1 2026, up 40.74% year-over-year from $4786.0 in Q1 2025, and up 9.49% quarter-over-quarter from $6152.0 in Q4 2025.
Nexalin Technology (NXL) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Nexalin Technology's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $6736.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 40.74% year-over-year to $6736.0; the TTM figure through Mar 2026 stood at $23486.0 (up 36.3% YoY), while the FY2025 annual figure was $21537.0, up 42.56% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $6736.0, up from $6152.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $6736.0 in Q1 2026, with the low at $660.0 in Q1 2023.
- The 4-year median for Amortizatization of Intangibles is $4211.0 (2024), against an average of $3625.4.
- The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles surged 459.23% in 2024, then increased 29.97% in 2025.
- Nexalin Technology's Amortizatization of Intangibles stood at $1646.0 in 2023, then soared by 169.81% to $4441.0 in 2024, then soared by 38.53% to $6152.0 in 2025, then gained by 9.49% to $6736.0 in 2026.
- Business Quant data shows NXL's Amortizatization of Intangibles at $6736.0 in Q1 2026, $6152.0 in Q4 2025, and $5473.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | - |
| 10 | Nexalin Technology | 6.98 Mn | 5.97 Mn | 8,897.00 | 20,325.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20,325.00 |
| Jun 30, 2026 | 20,325.00 |
| Mar 31, 2026 | 6,736.00 |
| Mar 31, 2026 | 6,736.00 |
| Dec 31, 2025 | 6,152.00 |
| Dec 31, 2025 | 6,152.00 |
| Sep 30, 2025 | 5,473.00 |
| Sep 30, 2025 | 5,473.00 |
| Jun 30, 2025 | 5,125.00 |
| Jun 30, 2025 | 5,125.00 |
| Mar 31, 2025 | 4,786.00 |
| Mar 31, 2025 | 4,786.00 |
| Dec 31, 2024 | 4,441.00 |
| Dec 31, 2024 | 4,441.00 |
| Sep 30, 2024 | 4,211.00 |
| Sep 30, 2024 | 4,211.00 |
| Jun 30, 2024 | 3,793.00 |
| Jun 30, 2024 | 3,793.00 |
| Mar 31, 2024 | 2,662.00 |
| Mar 31, 2024 | 2,662.00 |